Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AAMDC,Mth938 domain-containing protein,1562,150,1.37 [1.03-1.81],0.031170499057901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,1849,189,1.26 [1.02-1.57],0.0347540651708793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABL1,Tyrosine-protein kinase ABL1,1849,189,1.30 [1.09-1.54],0.0033441741895923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,1859,190,1.51 [1.00-2.27],0.0492049603849823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",1814,185,1.72 [1.44-2.07],3.9074651903816705e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN4,Alpha-actinin-4,1801,185,1.58 [1.18-2.12],0.0021136074106591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,1829,185,3.28 [2.21-4.87],3.539137290224895e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA,Adenosine deaminase,1864,187,1.49 [1.06-2.09],0.0223994140705922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,1842,186,1.79 [1.38-2.33],1.3846194073329816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,1548,150,1.62 [1.11-2.35],0.0116842047084977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,1864,187,1.63 [1.11-2.40],0.0132007346761347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1581,150,2.22 [1.46-3.37],0.0001777259601944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL2,ADAMTS-like protein 2,1604,153,1.42 [1.01-2.00],0.0430536949773512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,1829,185,2.07 [1.54-2.79],1.5872960435170496e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRD1,Adhesion G-protein coupled receptor D1,1570,146,1.52 [1.06-2.20],0.0243092793541875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,1853,187,2.45 [1.67-3.61],5.543738875372528e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,1862,190,2.24 [1.61-3.11],1.4381634337634872e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,1849,189,1.28 [1.14-1.43],2.202972361573341e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,1850,189,0.51 [0.33-0.79],0.0026827991475622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH1B,All-trans-retinol dehydrogenase,1570,146,0.83 [0.68-1.00],0.045330952317623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,1814,185,0.81 [0.70-0.94],0.0048351257929703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,1824,184,0.69 [0.56-0.85],0.0004611564464367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,1777,183,1.35 [1.20-1.52],1.0583051368245286e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR3,Anterior gradient protein 3,1796,185,1.34 [1.08-1.67],0.0083235005729597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,1853,187,1.84 [1.39-2.43],2.103101866543855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRP,Agouti-related protein,1864,187,1.33 [1.05-1.68],0.0160840289965494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKAP12,A-kinase anchor protein 12,1570,146,1.70 [1.01-2.87],0.0444275875225019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPI,Intestinal-type alkaline phosphatase,1548,150,1.16 [1.02-1.31],0.0188540685043982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,1864,189,3.27 [1.86-5.74],3.744510461710176e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,1849,189,1.82 [1.07-3.11],0.0272316134187229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,1851,187,1.97 [1.42-2.74],4.436389289577039e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,1848,187,1.99 [1.52-2.62],6.57773998379e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA10,Annexin A10,1788,185,1.17 [1.03-1.34],0.0197738560884034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA2,Annexin A2,1545,147,1.26 [1.01-1.57],0.0402463154212463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,1782,183,1.71 [1.14-2.57],0.0098618996991515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,1858,188,2.52 [1.71-3.71],3.185612789519371e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,1606,152,1.48 [1.11-1.97],0.0074765021727888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,1608,152,2.33 [1.69-3.21],2.059088273725285e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,1604,152,0.58 [0.38-0.89],0.0133635710958928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOH,Beta-2-glycoprotein 1,1855,188,1.47 [1.05-2.07],0.0244347852420732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APRT,Adenine phosphoribosyltransferase,1831,185,1.56 [1.17-2.08],0.002582782656915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,1849,189,1.76 [1.41-2.19],7.187001533649504e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,1537,150,1.28 [1.06-1.55],0.0089856007256836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,1858,188,1.60 [1.16-2.20],0.0041711084309365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,1832,185,1.92 [1.34-2.75],0.0004087589316597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,1606,152,2.55 [1.61-4.04],6.88645150914636e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASS1,Argininosuccinate synthase,1541,149,0.82 [0.68-0.99],0.034883888068818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG4A,Cysteine protease ATG4A,1798,185,1.31 [1.08-1.61],0.0074908593574497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATOX1,Copper transport protein ATOX1,1855,187,1.25 [1.03-1.52],0.0228723110254294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1D,V-type proton ATPase subunit D,1849,189,1.56 [1.08-2.26],0.0185130619048021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1F,V-type proton ATPase subunit F,1784,185,1.23 [1.02-1.50],0.0334015667965457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,1581,150,2.02 [1.39-2.94],0.0002340425787662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,1858,188,1.71 [1.11-2.64],0.0154633035332173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,1608,152,2.52 [1.73-3.67],1.5338099809050768e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1562,150,2.89 [1.94-4.31],1.846518031152867e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",1853,187,2.37 [1.60-3.52],1.8660946925563325e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,1798,185,1.77 [1.22-2.56],0.0024825284302216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,1832,185,0.58 [0.41-0.80],0.0011995545364531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2,Apoptosis regulator Bcl-2,1581,150,1.27 [1.01-1.60],0.044052689139547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",1840,187,1.48 [1.06-2.05],0.02009189714846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L15,Bcl-2-like protein 15,1548,150,1.31 [1.04-1.65],0.0217788914106918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BEX3,Protein BEX3,1538,145,1.23 [1.00-1.50],0.0491084965131782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,1604,153,0.86 [0.74-0.99],0.036906924130179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIRC2,Baculoviral IAP repeat-containing protein 2,1798,185,1.25 [1.02-1.54],0.0281012133610708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,1570,146,3.08 [1.80-5.25],3.647684124589877e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,1570,146,2.97 [1.57-5.62],0.0008452766636611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,1814,185,2.21 [1.31-3.74],0.0030989545147171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA1,BolA-like protein 1,1537,150,1.50 [1.15-1.94],0.0023638517022354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRK1,Protein BRICK1,1788,185,1.64 [1.25-2.14],0.0003364659016794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,1862,187,1.93 [1.12-3.31],0.0173119621574895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,1853,187,2.84 [2.07-3.90],1.3175177268515978e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN3A2,Butyrophilin subfamily 3 member A2,1840,187,1.78 [1.27-2.48],0.000774623558311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,1858,188,1.51 [1.16-1.95],0.002158159642927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1RL,Complement C1r subcomponent-like protein,1606,152,2.99 [1.39-6.44],0.0051501999566312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,1857,188,2.65 [1.39-5.07],0.0032243524714641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,1561,149,3.09 [2.11-4.51],5.687382105953471e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C8B,Complement component C8 beta chain,1608,152,0.53 [0.33-0.86],0.0097184114006105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,1849,189,2.52 [2.02-3.14],1.7927045157370882e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,1867,190,1.59 [1.16-2.16],0.0035828046354585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA3,Carbonic anhydrase 3,1867,190,1.28 [1.06-1.54],0.0112852168067279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,1869,190,1.63 [1.03-2.59],0.0381663298796846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,1867,190,1.51 [1.22-1.86],0.0001340029245412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,1537,150,1.27 [1.02-1.59],0.0308252176063401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB1,Calbindin,1849,189,1.41 [1.06-1.88],0.0195179243185549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,1788,185,2.16 [1.50-3.12],3.4460700951632226e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,1828,185,1.34 [1.12-1.61],0.0012904714369275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCB,Calcitonin gene-related peptide 2,1592,150,1.41 [1.12-1.78],0.0040960440616146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CARHSP1,Calcium-regulated heat-stable protein 1,1788,185,1.36 [1.09-1.70],0.0063568826747369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN4,Cerebellin-4,1867,190,0.55 [0.38-0.81],0.0022411322958736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,1864,187,2.17 [1.57-3.00],2.730468313239147e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,1869,190,1.80 [1.42-2.27],1.097270616779026e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL16,C-C motif chemokine 16,1869,190,1.24 [1.01-1.53],0.0429667586680718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,1864,187,1.64 [1.25-2.15],0.0003696347929059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL7,C-C motif chemokine 7,1840,187,1.28 [1.04-1.57],0.0203744298702713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN3,CCN family member 3,1861,190,1.79 [1.33-2.41],0.0001262683490094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,1867,190,1.63 [1.23-2.17],0.0006522039776437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,1855,188,1.57 [1.17-2.10],0.0027029558726255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,1855,188,2.36 [1.63-3.40],4.847636743917762e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,1826,186,1.74 [1.32-2.28],7.350172988167066e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,1864,187,1.75 [1.39-2.22],2.7561292879315285e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,1855,188,1.46 [1.21-1.75],5.197743198578592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164L2,CD164 sialomucin-like 2 protein,1557,147,1.42 [1.03-1.96],0.0322932656237512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,1840,187,1.89 [1.25-2.86],0.0024090877057944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,1825,188,2.06 [1.54-2.77],1.445951918374934e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,1855,187,2.34 [1.86-2.95],3.527258851781341e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,1832,185,1.82 [1.30-2.56],0.0005299450421555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,1841,187,2.58 [1.95-3.41],4.11648205788589e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,1798,185,1.78 [1.33-2.39],0.0001065858703603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2AP,CD2-associated protein,1850,189,1.23 [1.02-1.49],0.0279302956101771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300A,CMRF35-like molecule 8,1570,146,1.88 [1.17-3.04],0.0093056609095836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,1863,188,1.74 [1.25-2.43],0.0010048946645828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,1859,189,1.73 [1.32-2.28],7.759084568395252e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LG,CMRF35-like molecule 9,1855,188,1.51 [1.12-2.05],0.0076103410368331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,1849,189,2.47 [1.80-3.41],2.7188123362450174e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1849,189,1.80 [1.27-2.56],0.0009692937907333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,1843,187,1.35 [1.06-1.72],0.0137246577567391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,1844,187,2.53 [1.69-3.77],5.864880561913027e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,1848,187,2.19 [1.47-3.27],0.0001168378978455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,1864,189,2.38 [1.68-3.38],1.2630993973038414e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,1781,182,2.42 [1.61-3.65],2.3808268025502816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,1782,185,2.63 [1.76-3.93],2.676898944365581e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,1543,149,1.42 [1.03-1.96],0.034813778016787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD70,CD70 antigen,1840,187,1.82 [1.33-2.48],0.0001569010265377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,1863,188,2.01 [1.45-2.80],3.00324658310299e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,1864,187,1.72 [1.35-2.20],1.0606579352468262e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,1596,150,1.62 [1.11-2.38],0.0134978346422803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,1840,187,1.88 [1.36-2.59],0.0001129752980129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,1781,180,1.52 [1.04-2.22],0.0318159971656997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,1855,188,2.39 [1.34-4.28],0.003238250027203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99L2,CD99 antigen-like protein 2,1855,188,1.84 [1.13-3.00],0.0147974436446566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC27,Cell division cycle protein 27 homolog,1798,185,1.31 [1.07-1.59],0.0078797822873095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,1781,184,1.89 [1.53-2.33],2.163197226178246e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,1859,188,1.30 [1.07-1.59],0.0088473462843829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,1850,189,1.48 [1.27-1.73],5.4966471420337e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH23,Cadherin-23,1592,150,2.34 [1.42-3.86],0.0009116656189469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,1863,188,1.56 [1.14-2.14],0.0054809670542985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR2,Cadherin-related family member 2,1849,189,0.78 [0.67-0.91],0.001204694757899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDNF,Cerebral dopamine neurotrophic factor,1849,189,1.89 [1.34-2.66],0.0002634300364564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,1845,187,1.88 [1.17-3.01],0.0088932092043728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDSN,Corneodesmosin,1855,187,1.32 [1.01-1.73],0.0439056479682237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,1574,146,1.48 [1.12-1.96],0.0061495708784653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,1840,187,1.18 [1.03-1.36],0.0162567133012058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,1776,182,1.35 [1.13-1.63],0.0011832426038934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPJ,Centromere protein J,1574,146,1.26 [1.05-1.51],0.0131741113476468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP20,Centrosomal protein 20,1798,185,1.21 [1.03-1.42],0.0223005039370304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP43,Centrosomal protein 43,1801,182,1.24 [1.02-1.50],0.0290369108726345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,1849,189,1.35 [1.09-1.67],0.0052134097502623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFC1,Cryptic protein,1798,185,1.33 [1.04-1.70],0.0215622012181536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFD,Complement factor D,1608,152,2.25 [1.20-4.21],0.011517110748199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,1855,188,1.23 [1.03-1.47],0.0193738252349214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,1850,189,1.91 [1.50-2.44],1.973496215999661e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,1798,185,1.23 [1.03-1.47],0.0224545404828386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,1570,146,0.63 [0.48-0.82],0.0005534369010127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1592,150,2.19 [1.63-2.94],1.7933672420068528e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,1604,153,1.19 [1.07-1.33],0.0019499591706677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,1856,188,1.53 [1.18-1.98],0.0012398794862798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,1804,185,1.30 [1.12-1.50],0.0004451825151704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,1848,187,1.78 [1.23-2.58],0.0023439254333714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRM1,Muscarinic acetylcholine receptor M1,1557,147,1.51 [1.12-2.03],0.0062725938966896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIAPIN1,Anamorsin,1855,187,1.29 [1.05-1.58],0.0150756308509256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,1604,153,1.61 [1.24-2.08],0.0003540606799734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIT,Citron Rho-interacting kinase,1557,147,1.45 [1.07-1.95],0.0149814540603147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,1858,187,2.50 [1.80-3.48],5.788372194411058e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,1604,153,1.61 [1.31-1.98],6.749094568838328e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",1836,185,1.38 [1.12-1.68],0.0020260868012284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,1855,188,2.26 [1.59-3.23],6.38242013604431e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1A,C-type lectin domain family 1 member A,1814,185,2.15 [1.56-2.94],2.1113105828474608e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,1564,145,0.31 [0.16-0.60],0.000607504477428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4C,C-type lectin domain family 4 member C,1840,187,0.71 [0.55-0.92],0.0099621316940287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,1846,189,2.22 [1.49-3.33],9.902859080780372e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,1864,187,1.47 [1.14-1.91],0.0033524204221019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,1867,190,2.17 [1.27-3.69],0.004463021270024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLTA,Clathrin light chain A,1814,185,1.31 [1.01-1.69],0.041006346657813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN4,Contactin-4,1855,188,1.89 [1.13-3.15],0.0145106275577381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN5,Contactin-5,1847,188,0.63 [0.45-0.87],0.0054664203818992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,1852,190,3.13 [1.96-5.01],1.7265127673834022e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,1850,189,1.77 [1.37-2.29],1.538164996683263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,1869,190,2.14 [1.62-2.81],6.146627496515005e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,1841,187,2.83 [1.93-4.16],1.1167141230854437e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO6,Coronin-6,1537,150,1.49 [1.10-2.00],0.0088406240401608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA1,Carboxypeptidase A1,1869,190,0.82 [0.69-0.99],0.0346132446461769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,1858,188,1.39 [1.18-1.63],6.758153271326546e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPE,Carboxypeptidase E,1851,189,0.72 [0.53-0.96],0.0266169309964133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,1863,188,1.25 [1.03-1.51],0.0218607687892321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,1596,150,1.93 [1.13-3.31],0.0164016960476081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,1829,185,0.52 [0.37-0.73],0.0001478839200253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD1,Protein disulfide isomerase CRELD1,1570,146,1.59 [1.11-2.29],0.0122413395592704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD2,Protein disulfide isomerase CRELD2,1848,187,1.27 [1.01-1.59],0.0403786691808066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHBP,Corticotropin-releasing factor-binding protein,1841,187,1.59 [1.03-2.45],0.0355784774857048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIP2,Cysteine-rich protein 2,1832,185,1.79 [1.33-2.42],0.0001457527864194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP2,Cysteine-rich secretory protein 2,1867,190,0.82 [0.68-0.98],0.03045611928012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,1587,149,0.35 [0.20-0.62],0.000304241227296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,1832,185,1.30 [1.02-1.67],0.0334123944684969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB2,Beta-crystallin B2,1592,150,1.17 [1.02-1.34],0.0210653734909818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,1853,187,2.22 [1.50-3.31],7.90385771589807e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG4,Chondroitin sulfate proteoglycan 4,1604,153,1.74 [1.12-2.68],0.013014320850308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,1851,188,2.21 [1.56-3.14],7.703916399483538e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST5,Cystatin-D,1816,184,1.29 [1.04-1.61],0.0218648136353628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSTB,Cystatin-B,1822,188,1.75 [1.32-2.32],9.127070262722032e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,1604,153,1.96 [1.25-3.06],0.0033458486279598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTLA4,Cytotoxic T-lymphocyte protein 4,1604,153,0.56 [0.33-0.94],0.0297634993668951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTNNA1,Catenin alpha-1,1537,150,1.53 [1.07-2.18],0.0183306511394192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRC,Chymotrypsin-C,1841,187,0.78 [0.66-0.92],0.0040205383006383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,1570,146,1.52 [1.16-1.98],0.0022179568087663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,1850,189,1.93 [1.17-3.19],0.0101910899128354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,1864,187,1.58 [1.07-2.33],0.0207837057152168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,1438,143,2.78 [1.42-5.42],0.0028023828088883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSV,Cathepsin L2,1863,190,0.70 [0.53-0.92],0.0104274843726531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,1853,188,1.94 [1.35-2.79],0.0003784264071562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,1832,185,2.05 [1.50-2.81],7.765454604927073e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXADR,Coxsackievirus and adenovirus receptor,1840,187,1.28 [1.01-1.62],0.0381907044817819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL16,C-X-C motif chemokine 16,1866,190,1.76 [1.09-2.84],0.0198912811732284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL8,Interleukin-8,1832,185,1.23 [1.05-1.44],0.012438025887192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,1853,187,1.36 [1.16-1.59],0.0001562388624002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTL1,Cytokine-like protein 1,1604,153,0.44 [0.24-0.82],0.0099365354371012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAG1,Dystroglycan,1853,187,1.44 [1.09-1.90],0.0101492236029686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBI,Acyl-CoA-binding protein,1843,187,1.23 [1.04-1.46],0.0171880498592304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1855,187,2.50 [1.82-3.43],1.4530533193060997e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,1814,185,3.41 [2.14-5.44],2.618123023322966e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN6,Dynactin subunit 6,1788,185,1.16 [1.00-1.34],0.0498356497630205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,1855,187,0.75 [0.59-0.95],0.0172750342808828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",1849,189,1.50 [1.15-1.97],0.0031351994551965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX25,ATP-dependent RNA helicase DDX25,1557,147,1.52 [1.20-1.93],0.000546345559035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB103A_DEFB103B,Beta-defensin 103,1542,149,1.36 [1.07-1.73],0.0116753392319818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DFFA,DNA fragmentation factor subunit alpha,1864,187,1.22 [1.01-1.47],0.0395375124208328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,1831,185,1.98 [1.58-2.49],3.099546092232487e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,1855,187,2.71 [1.94-3.78],5.170080997875317e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,1562,150,0.73 [0.59-0.91],0.0046555212453937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB1,DnaJ homolog subfamily B member 1,1849,189,1.19 [1.03-1.37],0.021128048969181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC9,DnaJ homolog subfamily C member 9,1581,150,1.23 [1.01-1.50],0.0377791502934227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,1849,189,2.04 [1.46-2.85],3.222140049891238e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPT,Dermatopontin,1869,190,1.87 [1.13-3.09],0.0144912563115299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPY30,Protein dpy-30 homolog,1859,189,1.33 [1.09-1.61],0.0041007496985015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,1834,185,2.08 [1.68-2.58],1.3356076666789282e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,1855,188,2.12 [1.43-3.13],0.0001693099111012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,1841,189,0.61 [0.47-0.78],6.937724174085532e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTNB,Dystrobrevin beta,1590,149,1.57 [1.13-2.18],0.0074899156928655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,1849,189,2.84 [1.74-4.62],2.8870421883840698e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP3,Dual specificity protein phosphatase 3,1788,185,1.16 [1.02-1.32],0.0250725079718192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,1862,190,1.96 [1.34-2.88],0.0005920070081482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,1867,190,2.24 [1.79-2.80],2.2326183686128188e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDDM3B,Epididymal secretory protein E3-beta,1593,150,0.65 [0.43-0.97],0.0349832149639829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,1541,149,1.47 [1.01-2.13],0.0429210709051929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,1562,150,1.68 [1.02-2.76],0.0427645312887465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,1581,150,2.06 [1.31-3.25],0.0017881375374756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,1855,188,1.80 [1.26-2.57],0.0012777436778507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,1854,188,2.77 [1.98-3.87],3.0260133841798542e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,1829,185,3.53 [2.61-4.78],3.2195345494492647e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNB2,Ephrin-B2,1557,147,1.31 [1.06-1.61],0.0112795078093276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",1592,150,1.29 [1.05-1.60],0.0178043833178451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,1850,189,1.34 [1.12-1.59],0.001303232002664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENAH,Protein enabled homolog,1801,185,1.40 [1.08-1.82],0.0113491287181121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA1,Ephrin type-A receptor 1,1850,185,1.50 [1.06-2.14],0.0238482489754752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,1787,181,2.72 [2.11-3.51],1.154962480232553e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA4,Ephrin type-A receptor 4,1570,146,1.75 [1.03-2.98],0.0398838538333294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,1869,190,2.93 [2.03-4.24],1.1882638160355228e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,1828,185,1.81 [1.27-2.57],0.0010287886076703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,1840,187,1.25 [1.08-1.44],0.0025095441681398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,1864,189,1.76 [1.25-2.47],0.0010707081986039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,1855,187,0.55 [0.35-0.89],0.0136260422650165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,1855,187,1.54 [1.02-2.32],0.0414653103149835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERMAP,Erythroid membrane-associated protein,1548,150,1.74 [1.23-2.48],0.0019660135978827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,1869,190,1.88 [1.32-2.68],0.0005128893933587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESPL1,Separin,1538,145,1.28 [1.01-1.61],0.0380885688353782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2R,Proteinase-activated receptor 1,1848,187,1.48 [1.18-1.84],0.0005848913618869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,1854,188,1.58 [1.07-2.33],0.0221604336549472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",1841,187,1.22 [1.08-1.38],0.0012442836170527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",1596,150,1.80 [1.43-2.28],7.434719570931075e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",1869,190,1.69 [1.42-2.03],7.968831864787425e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP5,Fatty acid-binding protein 5,1860,187,1.45 [1.22-1.72],2.560246906179633e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,1849,189,2.20 [1.59-3.04],1.6978819907428474e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,1850,189,2.99 [2.16-4.13],4.55401497972102e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,1581,150,1.69 [1.41-2.03],1.9258009180024428e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,1864,190,1.47 [1.10-1.98],0.0097864373816126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBLN2,Fibulin-2,1604,153,1.49 [1.01-2.22],0.0462292483074284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBP1,"Fructose-1,6-bisphosphatase 1",1850,189,0.82 [0.70-0.97],0.0190250178991349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL6,Fc receptor-like protein 6,1840,187,1.21 [1.01-1.46],0.042535528744729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF23,Fibroblast growth factor 23,1863,189,1.35 [1.15-1.59],0.0002451053320754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF3,Fibroblast growth factor 3,1548,150,1.80 [1.07-3.03],0.0255230299177284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,1801,185,2.26 [1.59-3.20],4.811906493529308e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,1855,187,0.46 [0.31-0.67],5.536850399146312e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,1604,153,0.64 [0.47-0.86],0.0030230794884216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,1606,152,1.54 [1.22-1.94],0.0002478779670414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,1832,185,1.60 [1.17-2.19],0.0030210278460089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1832,185,1.61 [1.10-2.35],0.013713067522218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT1,Vascular endothelial growth factor receptor 1,1846,189,1.74 [1.06-2.84],0.0273607739109391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,1608,152,0.45 [0.26-0.80],0.0062307402064475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,1845,185,1.99 [1.35-2.93],0.0004572873709155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,1562,150,1.28 [1.00-1.63],0.0467193548385411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,1562,150,3.20 [1.81-5.68],6.561409657988443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,1841,185,1.81 [1.32-2.49],0.0002140890178533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,1855,187,0.60 [0.42-0.87],0.0063572054458964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUS,RNA-binding protein FUS,1794,184,1.69 [1.21-2.34],0.0018499987398939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,1863,188,1.39 [1.08-1.80],0.0111785710886132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAL,Galanin peptides,1853,187,0.75 [0.61-0.92],0.0061978079168875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,1849,189,1.66 [1.07-2.58],0.0234145780636133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,1801,185,1.63 [1.24-2.14],0.0004215179141307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,1798,185,1.30 [1.18-1.43],1.90768632519666e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",1849,189,1.51 [1.06-2.14],0.0223989537858012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,1869,190,2.14 [1.80-2.54],4.24884763530034e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDNF,Glial cell line-derived neurotrophic factor,1788,185,1.69 [1.28-2.22],0.0001751569300466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,1862,190,2.97 [2.08-4.25],2.491545463965382e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA2,GDNF family receptor alpha-2,1849,189,1.92 [1.04-3.55],0.0367503062022882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,1825,184,1.87 [1.23-2.83],0.0033562110477458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGH,Gamma-glutamyl hydrolase,1819,185,0.56 [0.38-0.82],0.0031474679426351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,1832,185,2.26 [1.40-3.67],0.0009118075694537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,1850,189,1.08 [1.00-1.16],0.0473759956412543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,1570,146,0.44 [0.26-0.73],0.0015965735762131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIGYF2,GRB10-interacting GYF protein 2,1601,151,1.24 [1.01-1.51],0.0395816234737918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,1562,150,1.39 [1.07-1.81],0.012908275818637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,1592,150,1.84 [1.18-2.88],0.007105628199063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLOD4,Glyoxalase domain-containing protein 4,1840,185,1.55 [1.08-2.22],0.0182743780745355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLP1R,Glucagon-like peptide 1 receptor,1537,150,1.65 [1.26-2.17],0.0003043164329609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,1567,150,1.85 [1.38-2.48],3.664676984849425e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR,GMP reductase 1,1864,187,1.32 [1.02-1.71],0.0345548562578385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,1849,189,0.90 [0.82-0.99],0.0351020446145198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,1867,190,1.68 [1.12-2.52],0.0129158447424433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPKOW,G-patch domain and KOW motifs-containing protein,1788,185,1.43 [1.00-2.04],0.0471379487654546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,1804,184,2.73 [1.78-4.18],4.292880701646539e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR101,Probable G-protein coupled receptor 101,1537,150,1.26 [1.01-1.57],0.0378440965327323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,1814,185,1.68 [1.40-2.00],1.1835926340599865e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,1848,188,3.98 [2.39-6.61],1.0234465535460369e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,1847,189,0.84 [0.73-0.97],0.0183065542210746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,1846,187,2.05 [1.55-2.71],3.89905702211276e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,1864,189,1.67 [1.44-1.93],5.136437664467865e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,1855,188,1.96 [1.42-2.70],4.1550769353973074e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,1596,150,3.14 [1.83-5.37],3.1256366746584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",1601,151,1.89 [1.17-3.06],0.0091481619831377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1840,187,2.79 [1.97-3.96],8.543608472081856e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX2,Heme oxygenase 2,1788,185,1.29 [1.00-1.65],0.0459291648655222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,1562,150,1.46 [1.12-1.91],0.0055298172710727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSBP1,Heat shock factor-binding protein 1,1562,150,1.21 [1.03-1.44],0.0224937862095273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA2,Heat shock-related 70 kDa protein 2,1593,150,1.47 [1.05-2.07],0.0255144045650956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,1867,190,1.68 [1.26-2.24],0.0004350316991171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1840,185,1.96 [1.36-2.83],0.0002945862144337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1B,5-hydroxytryptamine receptor 1B,1537,150,1.46 [1.07-2.01],0.0181751806182546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,1869,190,1.97 [1.17-3.30],0.0106872848859458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,1869,190,1.53 [1.03-2.28],0.0349058440776845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,1853,187,2.40 [1.41-4.09],0.0012825252750017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,1849,189,2.99 [1.70-5.24],0.0001321883979491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2R,Cation-independent mannose-6-phosphate receptor,1855,188,1.98 [1.16-3.38],0.0122747420378097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,1867,190,1.13 [1.02-1.26],0.0196406070090393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,1867,190,1.49 [1.26-1.76],2.874051865449776e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,1858,188,0.63 [0.46-0.85],0.0024023234504207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,1829,185,1.82 [1.49-2.23],8.459378333133776e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,1849,187,1.81 [1.31-2.50],0.0002973932677671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGHMBP2,DNA-binding protein SMUBP-2,1541,149,1.36 [1.06-1.74],0.0156271063251544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLC2,Immunoglobulin lambda constant 2,1601,150,2.15 [1.34-3.45],0.00147175605691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF21,Immunoglobulin superfamily member 21,1562,150,0.61 [0.39-0.97],0.0386086488167209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,1850,189,1.99 [1.35-2.93],0.000552683124943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10,Interleukin-10,1801,185,1.23 [1.10-1.37],0.0003769179377447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,1853,187,1.92 [1.34-2.75],0.0003529669227231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12A_IL12B,Interleukin-12,1849,189,1.30 [1.12-1.50],0.0004892656998456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12B,Interleukin-12 subunit beta,1864,187,1.44 [1.16-1.80],0.0011315565467398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,1801,185,1.46 [1.05-2.03],0.0232037472861158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,1840,187,1.49 [1.08-2.04],0.0136042781786342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,1801,185,1.95 [1.37-2.76],0.0001994477740669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL16,Pro-interleukin-16,1864,187,1.30 [1.00-1.67],0.0476134005227086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,1801,185,1.41 [1.23-1.60],3.3964063490100055e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RA,Interleukin-17 receptor A,1855,188,1.45 [1.10-1.91],0.0083103379660954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,1817,185,1.33 [1.05-1.68],0.0161409174945764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18,Interleukin-18,1837,185,1.49 [1.15-1.93],0.0023142675051802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,1858,188,2.12 [1.50-2.99],1.835955186905718e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,1864,187,1.49 [1.07-2.09],0.0192089055579392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,1808,183,1.29 [1.10-1.52],0.0020208156642761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,1854,188,3.87 [2.49-6.02],1.7431723628387795e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,1864,190,1.66 [1.28-2.16],0.0001306241380093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22,Interleukin-22,1593,150,1.29 [1.04-1.59],0.019598982883807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,1840,187,1.70 [1.28-2.25],0.0002055091119668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,1840,187,1.40 [1.03-1.90],0.0305587145561964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6R,Interleukin-6 receptor subunit alpha,1842,185,1.57 [1.08-2.26],0.0171400651806876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL9,Interleukin-9,1574,146,1.33 [1.07-1.66],0.0110303625272832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,1784,185,1.24 [1.01-1.51],0.0362223864340355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMMT,MICOS complex subunit MIC60,1593,150,1.43 [1.11-1.86],0.0064464722851829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,1537,150,1.62 [1.09-2.42],0.0167768483205664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBB,Inhibin beta B chain,1570,146,1.43 [1.11-1.84],0.0055298128538659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1601,151,1.77 [1.32-2.38],0.0001517196563087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,1593,150,1.31 [1.04-1.65],0.0200960120062444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK1,Interleukin-1 receptor-associated kinase 1,1801,185,1.23 [1.03-1.48],0.0250107964131201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAM,Integrin alpha-M,1855,188,1.65 [1.14-2.40],0.0080675901754347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,1835,190,1.68 [1.13-2.50],0.0100410393842255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,1801,185,1.88 [1.23-2.88],0.0038083953602414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,1867,190,1.41 [1.09-1.83],0.0088787372910127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,1858,188,1.90 [1.36-2.65],0.0001566912694623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,1863,188,2.72 [1.89-3.92],8.054276954368966e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM3,Junctional adhesion molecule C,1570,146,1.37 [1.04-1.80],0.0272978339449228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNIP4,Kv channel-interacting protein 4,1788,185,1.28 [1.05-1.57],0.0168246753173674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHDC3L,KH domain-containing protein 3,1538,145,1.28 [1.08-1.52],0.0044096796856952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA0319,Dyslexia-associated protein KIAA0319,1592,150,1.64 [1.05-2.55],0.0285695067030858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF1C,Kinesin-like protein KIF1C,1541,149,1.57 [1.10-2.23],0.0123462635602247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL1,Kin of IRRE-like protein 1,1537,150,1.36 [1.05-1.77],0.0205630752621658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,1850,189,1.44 [1.05-1.97],0.0219222772212419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,1788,185,1.34 [1.13-1.59],0.0008915525333128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,1832,185,1.82 [1.33-2.48],0.0001672544241092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,1867,190,1.68 [1.44-1.97],8.179687350633803e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK7,Kallikrein-7,1524,144,0.49 [0.32-0.76],0.0012302653915826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,1864,187,2.12 [1.61-2.79],8.06047121204535e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,1864,187,1.66 [1.28-2.17],0.0001700243390627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,1592,150,1.55 [1.08-2.22],0.0162246455448327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",1834,186,1.50 [1.29-1.75],1.3646260553144882e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,1864,187,0.76 [0.59-0.97],0.0310150294480195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,1849,189,1.64 [1.27-2.13],0.0001912164498002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1841,187,1.60 [1.30-1.96],7.698368467608e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,1828,185,2.68 [2.06-3.48],1.4527020763950284e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBR,Delta(14)-sterol reductase LBR,1863,188,1.21 [1.04-1.42],0.0156677098253245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,1601,151,1.41 [1.17-1.69],0.0002695938328021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,1800,186,1.35 [1.02-1.80],0.0388041759809644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEFTY2,Left-right determination factor 2,1862,190,1.35 [1.06-1.72],0.014947084370115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEP,Leptin,1850,189,0.78 [0.63-0.96],0.0214677455304417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,1850,189,2.35 [1.62-3.41],6.603001346973903e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LETM1,Mitochondrial proton/calcium exchanger protein,1601,151,1.39 [1.07-1.80],0.0136744698910449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS1,Galectin-1,1850,189,1.90 [1.35-2.67],0.0002313791052942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,1847,188,1.87 [1.24-2.83],0.0028816885771973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,1841,187,1.87 [1.54-2.27],2.3391568465069415e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,1843,187,1.68 [1.17-2.41],0.004771330440606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHB,Lutropin subunit beta,1798,185,1.22 [1.05-1.41],0.00810944087207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,1847,185,1.21 [1.01-1.47],0.0434350466159676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,1840,187,3.07 [2.04-4.61],7.06670020323793e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,1801,185,1.33 [1.02-1.74],0.0330108867304516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB2,Lamin-B2,1592,150,1.82 [1.10-3.03],0.0206819762741912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,1601,151,1.95 [1.35-2.81],0.0003285831462233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPA,Apolipoprotein(a),1556,147,1.20 [1.09-1.32],0.0001424343122757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,1787,181,1.40 [1.16-1.69],0.0004515413796972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,1859,189,1.66 [1.16-2.38],0.0058546541909613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,1850,189,1.72 [1.28-2.31],0.0003347686500124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2,Low-density lipoprotein receptor-related protein 2,1557,147,1.51 [1.04-2.19],0.0293794137554146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRN1,Leucine-rich repeat neuronal protein 1,1801,185,0.64 [0.47-0.88],0.0054606410221559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,1869,190,1.85 [1.32-2.59],0.0003141169704911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,1833,185,2.36 [1.72-3.24],1.226861600065393e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,1832,184,1.66 [1.29-2.14],7.018508211678682e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,1826,182,1.93 [1.30-2.86],0.0010851430965279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,1798,185,1.32 [1.06-1.65],0.0142385208106363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,1825,185,1.26 [1.03-1.54],0.0250663448983273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAG,Myelin-associated glycoprotein,1557,147,0.60 [0.43-0.84],0.0026018426217279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,1596,150,2.10 [1.47-3.01],4.845069404825026e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC1,MANSC domain-containing protein 1,1855,187,1.59 [1.05-2.39],0.0276832725425463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,1858,188,1.60 [1.15-2.22],0.0050218482978829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCFD2,Multiple coagulation factor deficiency protein 2,1840,187,1.36 [1.02-1.83],0.0372126515703727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,1852,187,1.58 [1.27-1.96],3.447023706652501e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDM1,Nuclear protein MDM1,1557,147,1.93 [1.19-3.11],0.0072988943954405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1B,Meprin A subunit beta,1850,189,0.90 [0.81-1.00],0.0475087249586391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,1841,187,0.52 [0.35-0.77],0.0010939637578367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MERTK,Tyrosine-protein kinase Mer,1864,187,1.78 [1.15-2.76],0.0098667184145331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP2,Methionine aminopeptidase 2,1862,190,1.32 [1.04-1.68],0.0225879931243855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,1570,146,1.97 [1.27-3.05],0.0025568449358614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,1855,188,1.52 [1.22-1.90],0.0001796298570621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,1840,187,1.11 [1.01-1.22],0.0231180834202853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,1780,179,1.23 [1.06-1.42],0.0070172738891247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,1842,187,1.33 [1.09-1.63],0.0058202499330224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,1849,186,1.65 [1.33-2.05],6.310513816368151e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP13,Collagenase 3,1788,185,1.47 [1.00-2.15],0.0478679118420394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,1855,188,1.42 [1.15-1.76],0.0012511916882073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,1812,185,1.60 [1.23-2.07],0.0003852923114083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,1606,152,1.74 [1.09-2.77],0.0200012613711049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL52,"39S ribosomal protein L52, mitochondrial",1535,144,1.88 [1.09-3.24],0.0240099959370534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSMB,Beta-microseminoprotein,1843,184,1.21 [1.01-1.44],0.0375906198327098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,1863,188,1.42 [1.08-1.87],0.0117642840010678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSTN,Growth/differentiation factor 8,1814,185,0.76 [0.59-0.98],0.0351616356339248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",1592,150,1.67 [1.01-2.76],0.0441694220210137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,1788,185,1.80 [1.53-2.13],4.144304828739016e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC1,"Myosin-binding protein C, slow-type",1596,150,1.32 [1.09-1.61],0.0054326073101647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL4,Myosin light chain 4,1562,150,1.41 [1.11-1.79],0.0049575708942078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",1557,147,1.52 [1.16-1.99],0.0023566412520308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM3,Myomesin-3,1570,146,1.20 [1.01-1.42],0.0334797367306055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZB1,Marginal zone B- and B1-cell-specific protein,1850,187,1.29 [1.02-1.64],0.0370778635753208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,1570,146,2.89 [1.48-5.65],0.0018777617988843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAPRT,Nicotinate phosphoribosyltransferase,1592,150,1.53 [1.05-2.24],0.0285596296950443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,1855,187,2.41 [1.61-3.61],1.9511587835638283e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,1863,188,0.55 [0.41-0.73],4.190255872992058e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,1839,186,2.00 [1.48-2.71],8.196924747637387e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1581,150,2.43 [1.62-3.65],1.861585064796476e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,1867,190,3.06 [2.06-4.56],3.514947685698314e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",1798,185,1.22 [1.07-1.40],0.0042035264583029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,1850,189,2.64 [1.93-3.62],1.4681818508575052e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,1855,187,1.98 [1.56-2.50],1.1142527239711124e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,1782,184,2.40 [1.94-2.96],6.041587397758171e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,1855,187,0.60 [0.46-0.78],0.0001075868166057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,1864,187,2.61 [1.80-3.77],3.5855778225255066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGFR,Tumor necrosis factor receptor superfamily member 16,1596,150,1.69 [1.05-2.73],0.030904103094696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,1601,151,1.22 [1.01-1.48],0.0367181045378116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOP56,Nucleolar protein 56,1541,149,1.15 [1.02-1.30],0.0226402899917606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS1,"Nitric oxide synthase, brain",1788,185,1.36 [1.07-1.73],0.0119440610000316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS3,"Nitric oxide synthase, endothelial",1788,185,1.23 [1.01-1.49],0.0443853104033181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,1869,190,2.62 [1.23-5.54],0.0120536196958846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH2,Neurogenic locus notch homolog protein 2,1604,153,2.34 [1.35-4.06],0.0024101503948179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,1585,150,2.66 [1.75-4.05],4.743764993826642e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,1850,189,1.82 [1.38-2.39],1.9353608753079225e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPR1,Atrial natriuretic peptide receptor 1,1541,149,1.65 [1.17-2.31],0.0038249690950492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,1867,190,1.42 [1.18-1.72],0.0002587547879749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,1850,189,1.71 [1.17-2.48],0.0050814605513603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,1859,188,2.13 [1.42-3.20],0.0002532572447831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NSFL1C,NSFL1 cofactor p47,1863,188,1.24 [1.03-1.50],0.0244201357078662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,1592,150,1.76 [1.24-2.51],0.0016627642095011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,1850,189,1.17 [1.05-1.31],0.0033420907787859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUCB2,Nucleobindin-2,1866,190,1.53 [1.10-2.12],0.0109872814973378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT5,ADP-sugar pyrophosphatase,1855,188,1.40 [1.14-1.71],0.0011275166213375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OCLN,Occludin,1601,151,1.44 [1.06-1.96],0.0188623457332084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,1855,188,2.00 [1.55-2.58],8.424867910570038e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,1849,189,0.82 [0.68-0.98],0.0337818042570137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,1845,187,1.53 [1.06-2.20],0.0226778998650803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,P4HB,Protein disulfide-isomerase,1835,186,1.49 [1.07-2.08],0.0190215618673322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAK4,Serine/threonine-protein kinase PAK 4,1788,185,1.25 [1.02-1.52],0.0312946641700938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM,Paralemmin-1,1573,149,2.12 [1.43-3.13],0.0001771552563502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM2,Paralemmin-2,1592,150,1.89 [1.35-2.64],0.000195390750706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARK7,Parkinson disease protein 7,1855,188,1.28 [1.02-1.62],0.0360235027323962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,1581,150,1.65 [1.03-2.66],0.0375676854650186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,1850,189,1.47 [1.08-1.98],0.0127816525809059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,1581,150,1.63 [1.22-2.19],0.0010443764892531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,1864,188,1.40 [1.11-1.77],0.00530623841079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,1849,189,2.41 [1.64-3.55],7.773897990806853e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD5,Programmed cell death protein 5,1863,188,1.41 [1.14-1.75],0.0016678815254474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD6,Programmed cell death protein 6,1850,189,1.31 [1.03-1.67],0.0268134184365271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,1850,189,2.26 [1.53-3.33],3.9893589052731233e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEBP1,Phosphatidylethanolamine-binding protein 1,1855,188,1.39 [1.14-1.70],0.0012030826641756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,1562,150,2.01 [1.16-3.47],0.0125392708108075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN4,Prefoldin subunit 4,1538,145,1.29 [1.03-1.63],0.027860660932536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",1596,150,1.37 [1.06-1.78],0.0167905044903837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,1864,187,2.20 [1.49-3.24],7.50487455127033e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB1,Pleckstrin homology-like domain family B member 1,1581,150,1.65 [1.24-2.20],0.0005710374695085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1832,185,2.20 [1.43-3.38],0.000340622136209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,1829,188,1.27 [1.04-1.55],0.0171709663373799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,1831,185,2.04 [1.50-2.76],4.0527842952429865e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1855,188,3.03 [2.19-4.20],2.628373095863836e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,1855,188,1.71 [1.26-2.33],0.0006044847794852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,1850,189,1.38 [1.09-1.74],0.0071203272692445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,1570,146,0.80 [0.64-1.00],0.0452761713305547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,1596,150,2.91 [1.66-5.10],0.0001948304884305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,1832,185,1.42 [1.16-1.73],0.0008097246425466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,1855,188,0.46 [0.33-0.63],1.3532698352550242e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,1864,190,0.73 [0.58-0.91],0.0051087848373333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,1834,187,3.02 [2.03-4.50],5.0421239603014004e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",1592,150,0.72 [0.55-0.95],0.0179188347459199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN3,Perilipin-3,1850,189,1.58 [1.21-2.08],0.0009198790266113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,1857,190,3.77 [2.52-5.64],1.0342253144382015e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,1548,150,1.66 [1.33-2.07],8.422776092283385e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1849,189,1.75 [1.34-2.29],4.414270575038222e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POMC,Pro-opiomelanocortin,1562,150,0.73 [0.59-0.91],0.0046829589599086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON3,Serum paraoxonase/lactonase 3,1853,187,0.62 [0.44-0.87],0.0052363898334197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPME1,Protein phosphatase methylesterase 1,1849,189,1.28 [1.05-1.57],0.0168750786465576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,1601,151,1.55 [1.16-2.08],0.003164985322727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP3R1,Calcineurin subunit B type 1,1832,185,1.41 [1.04-1.93],0.0287710618054416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,1845,184,1.18 [1.05-1.33],0.0043726522083523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PQBP1,Polyglutamine-binding protein 1,1798,185,1.22 [1.01-1.48],0.0357362985846699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,1604,153,2.19 [1.51-3.17],3.813551505332942e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,1861,190,1.50 [1.07-2.12],0.0203726438509382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PREB,Prolactin regulatory element-binding protein,1801,185,1.50 [1.02-2.21],0.0373039354962811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,1841,187,2.27 [1.38-3.74],0.0013262296667039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG2,Bone marrow proteoglycan,1604,153,1.41 [1.10-1.81],0.00767982860626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,1557,147,1.65 [1.11-2.43],0.0122125124285896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRRT3,Proline-rich transmembrane protein 3,1562,150,1.45 [1.04-2.04],0.0300846018172565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,1846,189,1.48 [1.10-1.98],0.0087241628146549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,1841,185,1.69 [1.28-2.23],0.0001919364149791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,1594,152,3.16 [1.88-5.33],1.5423267657748112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,1832,185,1.42 [1.26-1.60],7.0901772900767075e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME2,Proteasome activator complex subunit 2,1821,184,1.52 [1.06-2.18],0.0218324704400843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG3,Proteasome assembly chaperone 3,1840,187,1.33 [1.06-1.67],0.0148373924390325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSRC1,Proline/serine-rich coiled-coil protein 1,1798,185,1.26 [1.04-1.54],0.0200021815580676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1788,185,1.74 [1.14-2.67],0.0106915022332565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,1838,186,2.15 [1.57-2.94],1.6689867475818582e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,1840,187,1.36 [1.06-1.73],0.01369570273888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,1788,185,1.99 [1.44-2.75],3.0850679477475605e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,1581,150,1.44 [1.06-1.95],0.0200448784346515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1827,185,1.81 [1.31-2.49],0.0002992168810822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,1869,190,1.65 [1.02-2.67],0.0415029935251722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,1840,187,1.57 [1.17-2.10],0.002391574278297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXN,Paxillin,1788,185,1.29 [1.02-1.62],0.0345960681832174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,1541,149,1.26 [1.11-1.43],0.0003047162709232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,1854,190,1.62 [1.03-2.56],0.0381487553681905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,1840,187,0.65 [0.50-0.86],0.0021082539509759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABGAP1L,Rab GTPase-activating protein 1-like,1801,185,1.28 [1.05-1.56],0.0137800705485582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP2,E3 SUMO-protein ligase RanBP2,1537,150,1.58 [1.01-2.45],0.0432582289887518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,1798,185,1.55 [1.17-2.05],0.0023848527891999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES2,Retinoic acid receptor responder protein 2,1859,188,1.35 [1.04-1.76],0.0225808323227058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,1601,151,1.51 [1.17-1.95],0.001594674831333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP1,Retinol-binding protein 1,1557,147,1.30 [1.10-1.54],0.0019674697860096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,1849,189,1.28 [1.09-1.50],0.0022856294696439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP7,Retinoid-binding protein 7,1581,150,1.34 [1.09-1.64],0.0058060097471643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCOR1,REST corepressor 1,1814,185,1.33 [1.08-1.63],0.0065730554789204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,1843,185,2.03 [1.72-2.41],1.301260798037574e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,1869,190,1.70 [1.45-1.99],3.3192723134477536e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,1869,190,1.51 [1.28-1.77],5.610990281959294e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,1845,187,2.03 [1.69-2.45],7.733121610808772e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,1855,188,2.30 [1.59-3.32],8.67201978597302e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,1850,189,1.53 [1.37-1.72],5.0720094896442095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,1863,188,1.56 [1.07-2.29],0.0222416327543762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,1863,188,1.77 [1.17-2.68],0.0064678769931545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS8,Regulator of G-protein signaling 8,1801,185,1.19 [1.02-1.38],0.023971393397377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,1606,152,2.74 [1.68-4.46],5.50289210857944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE4,Ribonuclease 4,1548,149,2.38 [1.38-4.10],0.0017163155557953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,1591,150,2.28 [1.54-3.39],4.172827298087813e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,1863,190,2.35 [1.83-3.01],1.5744656110066318e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,1562,150,2.29 [1.52-3.46],7.277410862282711e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO1,Roundabout homolog 1,1845,187,1.56 [1.07-2.28],0.0218040022917592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,1850,189,1.85 [1.29-2.65],0.0008487807390837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,1867,190,1.48 [1.02-2.16],0.038319464783545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,1867,190,1.83 [1.26-2.66],0.0015099081989958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100G,Protein S100-G,1601,151,0.63 [0.45-0.90],0.0103729384326256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,1814,185,1.35 [1.12-1.63],0.0019298234352175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT2,Thialysine N-epsilon-acetyltransferase,1574,146,0.76 [0.58-0.99],0.0393954336559411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,1863,188,3.07 [2.21-4.27],2.0572494223440565e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,1791,181,2.39 [1.80-3.18],2.058862156479108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF1,Scavenger receptor class F member 1,1869,190,1.61 [1.21-2.16],0.0012376570782393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,1863,188,2.27 [1.54-3.36],3.6796987999981664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,1858,189,1.98 [1.44-2.73],2.9048794954581245e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG3,Secretogranin-3,1845,187,1.46 [1.01-2.09],0.0425226549968156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB1A1,Uteroglobin,1850,187,1.56 [1.23-1.97],0.0002356920380231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,1801,185,2.10 [1.66-2.65],8.008630351892414e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCLY,Selenocysteine lyase,1859,189,0.73 [0.58-0.93],0.0114065188392708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,1562,150,1.79 [1.44-2.23],2.360077518064988e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3G,Semaphorin-3G,1570,146,1.47 [1.07-2.03],0.0185051868843644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,1864,190,2.00 [1.40-2.87],0.0001599459457569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,1591,150,1.74 [1.27-2.39],0.0006304056085708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA1,Alpha-1-antitrypsin,1576,149,6.69 [1.13-39.51],0.0360387800235839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA12,Serpin A12,1805,184,0.89 [0.79-1.00],0.0486651034322513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINC1,Antithrombin-III,1604,152,3.12 [1.25-7.76],0.014533219217265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI1,Neuroserpin,1566,146,0.46 [0.27-0.78],0.004015895914156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6,Seizure protein 6 homolog,1557,147,1.52 [1.04-2.24],0.0320100146720852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,1855,187,1.87 [1.24-2.80],0.0025715787367177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SF3B4,Splicing factor 3B subunit 4,1849,189,1.24 [1.05-1.47],0.0108772462125842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP1,Secreted frizzled-related protein 1,1828,185,1.50 [1.15-1.96],0.0028575245206111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GLB2,Endophilin-B2,1592,150,1.28 [1.03-1.60],0.0292575366217687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHBG,Sex hormone-binding globulin,1606,152,1.33 [1.03-1.72],0.0291457939864159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,1604,153,2.57 [1.72-3.84],4.109888374875577e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,1853,187,1.43 [1.09-1.88],0.0099327859378755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,1840,187,1.76 [1.25-2.49],0.0013750971612974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,1867,190,2.08 [1.44-3.01],8.74678807395744e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,1847,190,1.50 [1.17-1.92],0.0012727868280514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,1838,185,1.80 [1.39-2.33],9.53340984385848e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,1801,185,1.26 [1.02-1.57],0.0337850744443119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,1840,187,1.29 [1.04-1.60],0.0185128415391761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,1798,185,1.36 [1.07-1.73],0.0119272864979431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC13A1,Solute carrier family 13 member 1,1593,150,1.32 [1.08-1.61],0.0074660123339518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,1788,185,1.54 [1.20-1.97],0.000627779528912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC4A1,Band 3 anion transport protein,1604,153,1.45 [1.06-1.98],0.019752334342108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,1867,190,1.58 [1.15-2.18],0.0049452594218698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,1814,185,2.10 [1.49-2.95],2.374248908445484e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,1849,189,0.46 [0.24-0.87],0.0171780574620367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC1,SPARC-related modular calcium-binding protein 1,1867,190,1.67 [1.16-2.39],0.0057832623280119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,1853,187,1.66 [1.27-2.17],0.0002242194857787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,1850,185,0.80 [0.67-0.97],0.0231977198154108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,1832,185,1.43 [1.20-1.71],7.686489338302243e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",1562,150,1.68 [1.19-2.39],0.0034835866675693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX5,Sorting nexin-5,1562,150,1.68 [1.08-2.62],0.020925510662064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX9,Sorting nexin-9,1850,189,1.23 [1.03-1.48],0.0245190863963072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD1,Superoxide dismutase [Cu-Zn],1816,184,1.29 [1.00-1.66],0.0493029322001732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,1798,185,1.98 [1.45-2.70],1.713654962616669e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX9,Transcription factor SOX-9,1557,147,2.26 [1.25-4.10],0.0071482907704533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,1855,188,1.95 [1.63-2.33],1.933507977224921e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,1840,187,1.73 [1.48-2.01],1.898937469894067e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT1,Kunitz-type protease inhibitor 1,1851,188,1.71 [1.12-2.62],0.0129198372108552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,1853,187,1.70 [1.25-2.31],0.0007599301097619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT3,Kunitz-type protease inhibitor 3,1581,150,0.86 [0.77-0.96],0.0065396376173661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,1832,185,0.41 [0.25-0.65],0.0001800704532166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,1845,187,2.06 [1.50-2.83],8.094792842568046e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,1845,189,1.68 [1.24-2.29],0.0009045159096563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSH3,Protein phosphatase Slingshot homolog 3,1538,145,0.43 [0.23-0.82],0.0098579635018378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,1581,150,1.39 [1.07-1.82],0.0147361768686875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",1849,189,1.46 [1.11-1.94],0.0075851687060072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC1,Stanniocalcin-1,1863,188,1.43 [1.09-1.86],0.0091096927572168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,1855,188,1.55 [1.05-2.29],0.0259426368444405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD5,Sushi domain-containing protein 5,1561,145,1.57 [1.02-2.43],0.0425932966411715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,1652,168,1.77 [1.12-2.78],0.0136738680262858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,1849,189,1.80 [1.37-2.36],2.444344264125364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D17,TBC1 domain family member 17,1788,185,1.43 [1.14-1.79],0.0016981632249051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,1867,190,1.97 [1.41-2.76],6.665330379242496e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCP11,T-complex protein 11 homolog,1574,146,1.21 [1.01-1.45],0.0370690546266862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,1847,188,1.43 [1.27-1.62],1.572372517796002e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,1848,187,1.78 [1.50-2.12],5.30006175517745e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,1840,188,1.81 [1.51-2.17],1.2883549092976128e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,1840,187,1.58 [1.26-1.99],7.959034573082427e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,1842,185,0.44 [0.29-0.68],0.0002209659715296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,1855,187,2.00 [1.56-2.56],4.7062187595660374e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,1606,152,2.07 [1.26-3.41],0.0040712307080159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,1850,189,1.86 [1.28-2.72],0.0012794998644103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,1574,146,1.47 [1.05-2.04],0.0230008070846648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,1849,189,1.31 [1.13-1.50],0.0002276812604792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMSB10,Thymosin beta-10,1855,188,1.36 [1.14-1.62],0.0008174446225527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNC,Tenascin,1858,188,1.29 [1.01-1.65],0.0413493242888092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,1812,184,1.40 [1.11-1.78],0.0053320658139086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1832,185,3.33 [2.35-4.72],1.578137547970129e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1832,185,1.43 [1.25-1.65],2.60018739560098e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1864,187,2.23 [1.76-2.82],3.2502609114471985e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,1841,187,1.53 [1.08-2.18],0.0169990176249348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1855,187,2.15 [1.63-2.83],4.604269363285465e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,1845,187,1.84 [1.33-2.54],0.0002300517504484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1845,187,2.84 [2.14-3.77],3.822751805550757e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,1570,146,1.63 [1.13-2.35],0.0089694977857726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1867,190,2.07 [1.57-2.71],1.7753284372906385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1855,188,2.99 [2.18-4.11],1.2148553316226188e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1855,188,1.57 [1.31-1.87],7.14389130544151e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1863,188,1.75 [1.15-2.67],0.0087750919138435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1862,187,2.10 [1.61-2.74],3.760265065068416e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1832,185,1.48 [1.19-1.85],0.0004900891205561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,1863,188,1.52 [1.19-1.93],0.0006602311299495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1832,185,2.16 [1.67-2.78],3.376609914046825e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,1853,187,3.14 [2.08-4.74],5.517835899524077e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,1604,153,1.68 [1.15-2.45],0.0075822001003366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53,Cellular tumor antigen p53,1798,185,1.38 [1.03-1.86],0.0332765271254219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM24,Transcription intermediary factor 1-alpha,1569,146,1.25 [1.00-1.55],0.0489286428538543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,1850,189,0.85 [0.74-0.98],0.0221401619697493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN1,Tetraspanin-1,1814,185,2.04 [1.53-2.71],9.541508634182008e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTF2,Transcription termination factor 2,1557,147,1.42 [1.06-1.91],0.018581238924355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTN,Titin,1541,149,1.30 [1.09-1.56],0.0044313746445088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TUBB3,Tubulin beta-3 chain,1537,150,2.22 [1.28-3.83],0.0044030557594552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC5,Thioredoxin domain-containing protein 5,1863,188,1.29 [1.08-1.56],0.0059940968096271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBAC1,Ubiquitin-associated domain-containing protein 1,1849,189,1.41 [1.00-2.00],0.0493715502771328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,1832,185,1.86 [1.40-2.47],1.853123107623915e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,1860,187,0.57 [0.47-0.70],3.882764437113211e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPB1,Beta-ureidopropionase,1596,150,0.81 [0.70-0.95],0.0087634725191357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROS,Uroporphyrinogen-III synthase,1557,147,1.38 [1.12-1.71],0.0023294531809948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,1592,150,1.55 [1.15-2.10],0.0041481956602595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,1814,185,1.16 [1.02-1.33],0.0249267739151613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,1819,181,2.07 [1.36-3.15],0.0007158527058441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,1857,188,1.87 [1.26-2.78],0.0019425559018877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,1862,187,1.96 [1.40-2.75],9.406716966709888e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS37A,Vacuolar protein sorting-associated protein 37A,1849,189,1.20 [1.03-1.40],0.022909133181895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,1593,150,1.49 [1.24-1.80],2.476104444682133e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,1852,187,2.09 [1.65-2.65],1.2590465583818332e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,1592,150,0.57 [0.40-0.81],0.0019255598634521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM1,V-set and transmembrane domain-containing protein 1,1788,185,1.43 [1.11-1.83],0.0049090394604354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,1825,185,1.69 [1.25-2.29],0.0007208507403178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC12,WAP four-disulfide core domain protein 12,1865,190,1.24 [1.04-1.48],0.0189322209307259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,1761,176,2.08 [1.67-2.58],3.7885826625352846e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",1824,184,0.65 [0.48-0.89],0.0063924149493092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,1867,190,0.69 [0.48-1.00],0.0484362765438494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,1801,185,1.82 [1.40-2.36],7.834322467961716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,1867,190,1.27 [1.05-1.53],0.0148752512656047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,1859,189,2.09 [1.56-2.81],7.684417141797724e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XPNPEP2,Xaa-Pro aminopeptidase 2,1855,187,0.83 [0.72-0.95],0.0067632167953157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,1592,150,2.67 [1.73-4.12],9.901445094450922e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YJU2,Splicing factor YJU2,1593,150,1.64 [1.02-2.65],0.0419579019022326
